MD, US59271J1051

Pediatrix Medical Group stock rises on $0.63 EPS

Published on 09/03/2026 at 15:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Pediatrix Medical Group stock held near $26.94 as traders weighed a $0.63 second-quarter EPS and 4.1 percent revenue growth.

MD, US59271J1051, Illustration mit AI erstellt.
MD, US59271J1051, Illustration mit AI erstellt.

Pediatrix Medical Group stock (US59271J1051) traded at $26.94 on September 3, 2026, up $0.47 or 1.76 percent in morning trading, while MarketBeat listed a $2.19 billion market value and a 52-week range of $15.69 to $27.94.

Second-quarter numbers matter

MarketBeat said Pediatrix reported $0.63 EPS for the quarter announced on August 4, 2026, topping the $0.59 consensus by $0.04. The same source said quarterly revenue rose 4.1 percent from the prior year period.

For investors, the mix is clear: a 12.89 trailing P/E and a $25.00 consensus price target leave the stock above the market view, even after a 24.0 percent rise from $21.37 on January 1, 2026.

Consensus stays cautious

MarketBeat showed a Hold consensus, 7 analyst reports in the past 90 days and a short interest level of 6.19 percent of float. The same page also put institutional ownership at 97.71 percent, which keeps the register tightly held.

Go deeper

Why the second quarter set the tone

The latest quarter and the market data together show why the stock is being judged on execution rather than headlines.

Hospital care remains core

The company is a national physician-led group focused on high-acuity newborn, maternal-fetal and pediatric subspecialty care, with more than 3,500 physicians and advanced practice clinicians across over 1,300 facilities. That footprint explains why a 4.1 percent revenue increase and a $0.04 EPS beat can still move sentiment in a muted healthcare tape.

Market level holds

Pediatrix Medical Group stock stood at $26.94 on September 3, 2026, with the session range at $26.57 to $26.91 and a market capitalization of $2.19 billion. The stock was also up 24.0 percent from $21.37 at the start of 2026, leaving it above the $25.00 consensus target.

Pediatrix Medical Group at a glance

  • Company: Pediatrix Medical Group, Inc.
  • ISIN: US59271J1051
  • Ticker: MD
  • Trading venue: NYSE
  • Price (as of September 3, 2026, 10:07 AM Eastern): USD 26.94
  • Market capitalization: USD 2.19 billion (as of September 3, 2026)
  • Sector / Industry: Healthcare / Healthcare Providers and Services
  • Index membership: Russell 2000

Disclaimer...

en | US59271J1051 | MD | boerse | 70049161 | bgmi